← Back to Bills
HR 8078118th CongressFailed / ExpiredHouse

Sepsis Harm and Cost Reduction Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Jul 29, 2024
Latest Action Date
Apr 26, 2024

Latest Action

Referred to the Subcommittee on Health.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Sepsis Harm and Cost Reduction Act (H.R. 8078) is a health policy bill introduced in the 118th Congress aimed at addressing the issues related to sepsis, a serious medical condition caused by the body's response to infection. Although the official summary and full text are not available, the bill's title and policy area indicate its focus on reducing harm and healthcare costs associated with sepsis. The bill was referred to the House Subcommittee on Health but did not advance further and is currently classified as failed or expired.

Bottom Line

H.R. 8078 sought to reduce the harm and costs related to sepsis but did not progress beyond subcommittee referral and is now expired.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill is focused on health policy, specifically targeting sepsis-related harm and costs.
  • It was introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
  • No official summary or full text is publicly available, limiting detailed analysis of provisions.
Who Benefits?

['Patients at risk of or suffering from sepsis', 'Healthcare providers involved in sepsis treatment', 'Health agencies focused on infectious disease and patient safety', 'Healthcare systems aiming to reduce costs associated with sepsis care']

Potential Concerns

['Lack of publicly available full text and summary limits understanding of implementation requirements and funding mechanisms.', 'Unclear oversight and enforcement provisions due to missing detailed legislative text.', 'Potential challenges in measuring cost reductions and harm mitigation without specified metrics.']

Political Context

The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health on April 26, 2024. It did not advance beyond this stage and is now classified as failed or expired. The absence of further legislative action suggests limited congressional momentum or prioritization within the health policy agenda during this session.

Hidden Impact Review

Hidden impact flags detected: 1

GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

1 Detected
Detected Flags
Indirect Effects

['If enacted, the bill could encourage development of new protocols or funding streams for sepsis treatment and prevention.', 'Potential reduction in healthcare costs related to sepsis might influence hospital resource allocation and insurance coverage policies.', 'Increased focus on sepsis could raise public and professional awareness, potentially improving early diagnosis and outcomes.']

GovScope Watchdog Notes

The absence of a publicly available official summary and full bill text significantly limits transparency and public understanding of the bill's specific provisions, funding, and enforcement mechanisms. This lack of documentation poses challenges for oversight and informed public discourse. Additionally, the bill's failure to progress beyond subcommittee referral indicates limited legislative engagement, which is important context for assessing its impact and relevance.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready